{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:36:16Z","timestamp":1790202976000,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.intimp.2018.10.028","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T21:59:07Z","timestamp":1541109547000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review"],"prefix":"10.1016","volume":"65","author":[{"given":"Francisco","family":"Herrera-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldo","family":"del Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-1923","authenticated-orcid":false,"given":"Armando","family":"Tejero-Pedregosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7642-5051","authenticated-orcid":false,"given":"Rosario","family":"Padilla-Berdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Maurtua-Brise\u00f1o-Meiggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-7838","authenticated-orcid":false,"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"San Segundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Heidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5678","authenticated-orcid":false,"given":"F. Javier","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3699","authenticated-orcid":false,"given":"Carlos","family":"Ochoa-Sangrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.10.028_bb0005","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0010","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2014a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2018.10.028_bb0015","first-page":"233","article-title":"Predicting, managing and preventing new-onset diabetes after transplantation","volume":"37","author":"Gosmanov","year":"2012","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0020","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/TP.0000000000001693","article-title":"mTOR Inhibition & cardiovascular diseases: dyslipidemia and atherosclerosis","volume":"102","author":"Kurdi","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semnephrol.2007.03.010","article-title":"Renal disease in recipients of nonrenal solid organ transplantation","volume":"27","author":"Ojo","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ki.2014.395","article-title":"A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft","volume":"87","author":"Baron","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0035","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.kint.2016.12.020","article-title":"A composite score associated with spontaneous operational tolerance in kidney transplant recipients","volume":"91","author":"Danger","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.tp.0000290683.54937.1b","article-title":"Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation","volume":"84","author":"Ashton-Chess","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-6143.2001.010103.x","article-title":"In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance","volume":"1","author":"Auchincloss","year":"2001","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0050","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/j.1600-6143.2011.03638.x","article-title":"Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients","volume":"11","author":"Lozano","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-6143.2006.01621.x","article-title":"Multiparameter immune profiling of operational tolerance in liver transplantation","volume":"7","author":"Mart\u00ednez-Llordella","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0060","first-page":"2845","article-title":"Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients","volume":"118","author":"Mart\u00ednez-Llordella","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.10.028_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/tri.12603","article-title":"Immunosuppressive minimization with mTOR inhibitors and belatacept","volume":"28","author":"Diekmann","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0075","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2006101143","article-title":"Regulatory T cells and T cell depletion: role of immunosuppressive drugs","volume":"18","author":"Noris","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0080","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.tp.0000284808.28353.2c","article-title":"Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury","volume":"84","author":"Ruggenenti","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trim.2010.04.004","article-title":"Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine","volume":"23","author":"Morelon","year":"2010","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075591","article-title":"Deferred pre-emptive switch from calcineurin inhibitor to sirolimus leads to improvement in GFR and expansion of T regulatory cell population: a randomized, controlled trial","volume":"8","author":"Bansal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.10.028_bb0095","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2013.337","article-title":"Rapamycin induces ILT3(high)ILT4(high) dendritic cells promoting a new immunoregulatory pathway","volume":"85","author":"Stallone","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trim.2015.07.005","article-title":"Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: results from a single-center randomized trial","volume":"33","author":"Libetta","year":"2015","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0110","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/ajt.12712","article-title":"Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors","volume":"14","author":"Kirk","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ajt.13469","article-title":"Postdepletion lymphocyte reconstitution during belatacept and rapamycin treatment in kidney transplant recipients","volume":"16","author":"Xu","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0272989X12452341","article-title":"Assessing personalized medicines in Australia: a national framework for reviewing codependent technologies","volume":"33","author":"Merlin","year":"2013","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.intimp.2018.10.028_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mcna.2016.01.002","article-title":"Acute and chronic allograft dysfunction in kidney transplant recipients","volume":"100","author":"Goldberg","year":"2016","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.intimp.2018.10.028_bb0130","series-title":"Procedural Guidance for the Systematic Evaluation of Biomarker Tests \u2013 Decision Support Document Nr. 77","first-page":"37","author":"Assessment of co-dependent technologies","year":"2014"},{"key":"10.1016\/j.intimp.2018.10.028_bb0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1208\/s12248-011-9265-x","article-title":"Translational biomarkers: from preclinical to clinical a report of 2009 AAPS\/ACCP biomarker workshop","volume":"13","author":"Bai","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.intimp.2018.10.028_bb0140","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2018.11.083","article-title":"Briefs for the article: the number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: a multistage systematic review","author":"Herrera-G\u00f3mez","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.intimp.2018.10.028_bb0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/jcm7090262","article-title":"Correction of hyponatremia may be a treatment stratification biomarker: a two-stage systematic review and meta-analysis","volume":"7","author":"Herrera-G\u00f3mez","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0155","doi-asserted-by":"crossref","first-page":"b375","DOI":"10.1136\/bmj.b375","article-title":"Prognosis and prognostic research: what, why, and how?","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0160","series-title":"Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee \u2013 Version 5.0","first-page":"144","article-title":"Product type 4 \u2013 codependent technologies","year":"2016"},{"key":"10.1016\/j.intimp.2018.10.028_bb0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0175","series-title":"Cochrane Handbook for Systematic Reviews of Interventions \u2013 Version 5.1.0.","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.intimp.2018.10.028_bb0180","series-title":"Systematic Reviews: Centre for Reviews and Dissemination's (CRD) Guidance for Undertaking Reviews in Health Care","author":"Centre for Reviews and Dissemination","year":"2008"},{"key":"10.1016\/j.intimp.2018.10.028_bb0185","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0190","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans","volume":"120","author":"Sagoo","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.10.028_bb0195","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"120","author":"Newell","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.10.028_bb0200","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/ajt.13480","article-title":"Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients","volume":"15","author":"Newell","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1681\/ASN.2005020178","article-title":"Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients","volume":"17","author":"Baeten","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0210","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4\u202f+\u202fT cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0215","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1432-2277.2007.00537.x","article-title":"Variation in numbers of CD4\u202f+\u202fCD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome","volume":"20","author":"Braudeau","year":"2007","journal-title":"Transpl. Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0220","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ajt.12508","article-title":"Unique B cell differentiation profile in tolerant kidney transplant patients","volume":"14","author":"Chesneau","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0230","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2014050480","article-title":"Central role of CD45RA- Foxp3hi memory regulatory T cells in clinical kidney transplantation tolerance","volume":"26","author":"Braza","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0235","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.humimm.2010.01.022","article-title":"Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals","volume":"71","author":"Moraes-Vieira","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2119\/molmed.2011.00281","article-title":"Preserving the B-cell compartment favors operational tolerance in human renal transplantation","volume":"18","author":"Silva","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0245","series-title":"Etudes d'un Protocole Clinique de Minimisation des Corticost\u00e9ro\u00efdes et de la Tol\u00e9rance Op\u00e9rationnelle Chez des Patients Transplant\u00e9s R\u00e9naux","author":"Louis","year":"2005"},{"key":"10.1016\/j.intimp.2018.10.028_bb0250","series-title":"\u00c9tude du Phenotype et de la Fonction des Cellules Regulatrices T CD4+ CD25+ dans le Sang des Patients Tol\u00e9rants Spontanement un Greffe de rein","author":"Braudeau","year":"2006"},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2018.10.028_bb0255","first-page":"65","article-title":"Indices of tolerance: interim report, World Transplant Congress 2006; 2006 July 22\u201327; Boston, Massachusetts, USA","volume":"6","author":"Hernandez-Fuentes","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"Suppl. 11","key":"10.1016\/j.intimp.2018.10.028_bb0260","first-page":"155","volume":"5","author":"Baeten","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2018.10.028_bb0265","volume":"186","author":"Silva","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0270","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2018.10.028_bb0280","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-1870-2","article-title":"Why clinical trial outcomes fail to translate into benefits for patients","volume":"18","author":"Heneghan","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2018.10.028_bb0290","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0295","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0300","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.medcli.2017.05.008","article-title":"Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review","volume":"149","author":"Herrera-G\u00f3mez","year":"2017","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.intimp.2018.10.028_bb0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/TP.0000000000000942","article-title":"Pretransplant recipient circulating CD4+CD127lo\/\u2212 tumor necrosis factor receptor 2+ regulatory T cells: A surrogate of regulatory T cell-suppressive function and predictor of delayed and slow graft function after kidney transplantation","volume":"100","author":"Nguyen","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0310","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ajt.13122","article-title":"Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study","volume":"15","author":"Shabir","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0315","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/TP.0000000000000202","article-title":"High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter study","volume":"98","author":"San Segundo","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2018.10.028_bb0320","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.transproceed.2015.09.007","article-title":"Activated regulatory T cells expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) biomarkers could be a risk factor in liver allograft rejection","volume":"47","author":"Boix-Giner","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.intimp.2018.10.028_bb0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxv048","article-title":"High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation","volume":"28","author":"Boix-Giner","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0330","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/tri.12998","article-title":"Regulatory T cell therapy in liver transplantation","volume":"30","author":"Whitehouse","year":"2017","journal-title":"Transpl. Int."},{"key":"10.1016\/j.intimp.2018.10.028_bb0335","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/MOT.0b013e32834c237a","article-title":"Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?","volume":"16","author":"Zuber","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.intimp.2018.10.028_bb0340","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.intimp.2018.10.028_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cellimm.2011.05.006","article-title":"Do CD4+Foxp3+ Treg cells correlate with transplant outcomes: a systematic review on recipients of solid organ transplantation","volume":"270","author":"Shan","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1756-5391.2010.01083.x","article-title":"The effects of immunosuppressive drugs on CD4(+) CD25(+) regulatory T cells: a systematic review of clinical and basic research","volume":"3","author":"Zhang","year":"2010","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.intimp.2018.10.028_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-1-7","article-title":"Why prospective registration of systematic reviews makes sense","volume":"1","author":"Stewart","year":"2012","journal-title":"Syst. Rev."},{"key":"10.1016\/j.intimp.2018.10.028_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009810","article-title":"Bias due to changes in specified outcomes during the systematic review process","volume":"5","author":"Kirkham","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2018.10.028_bb0365","doi-asserted-by":"crossref","first-page":"f4501","DOI":"10.1136\/bmj.f4501","article-title":"Overlapping meta-analyses on the same topic: survey of published studies","volume":"347","author":"Siontis","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0370","doi-asserted-by":"crossref","first-page":"f5040","DOI":"10.1136\/bmj.f5040","article-title":"The problem of duplicate systematic reviews","volume":"347","author":"Moher","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1752-8062.2011.00291.x","article-title":"Evaluating translational research: a process marker model","volume":"4","author":"Trochim","year":"2011","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.intimp.2018.10.028_bb0380","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.289.10.1278","article-title":"Central challenges facing the national clinical research enterprise","volume":"289","author":"Sung","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2018.10.028_bb0385","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jama.2007.26","article-title":"The meaning of translational research and why it matters","volume":"299","author":"Woolf","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2018.10.028_bb0390","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.intimp.2018.10.028_bb0395","series-title":"The Handbook of Research Synthesis","first-page":"97","article-title":"Judging research quality","author":"Wortman","year":"1994"},{"key":"10.1016\/j.intimp.2018.10.028_bb0400","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"Terrin","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2018.10.028_bb0405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.intimp.2018.10.028_bb0410","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/bmj.308.6921.72","article-title":"Who benefits from medical interventions?","volume":"308","author":"Smith","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2018.10.028_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00845","article-title":"Effects of intensive control of glycemia on clinical kidney outcomes in type 2 diabetes patients compared with standard control: a meta-analysis","volume":"8","author":"Herrera-G\u00f3mez","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918305939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918305939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T02:07:38Z","timestamp":1662343658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918305939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":83,"alternative-id":["S1567576918305939"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.028","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}